tradingkey.logo
tradingkey.logo
Search

Tempest Therapeutics Inc

TPST
Add to Watchlist
0.856USD
-0.007-0.86%
Close 07-31 16:00ETQuotes delayed by 15 min
12.28MMarket Cap
0.03P/E TTM

TPST Financials

See Tempest Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Tempest Therapeutics Inc Earnings Date

Latest Release
May 14, 2026
EPS / Forecast
-2.53/-0.28
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-6.33
67.54%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
93.83%-2.53
81.29%-0.82
85.13%-0.79
62.50%-2.07
-788.67%-41.07
12.31%-4.38
14.88%-5.32
21.04%-5.52
35.93%-4.62
41.97%-5.00
---6.25
---6.99
---7.21
---8.61
---31.98
----
----
----
----
----
Net Profit
-155.03%-27.70M
70.89%-4.02M
66.74%-3.51M
17.76%-7.87M
-37.40%-10.86M
-84.47%-13.81M
-55.56%-10.56M
-26.24%-9.57M
-3.51%-7.90M
17.74%-7.49M
24.15%-6.79M
17.31%-7.58M
10.07%-7.64M
-17.02%-9.10M
-10.32%-8.95M
-29.90%-9.17M
-1.22%-8.49M
-5.66%-7.78M
-27.24%-8.11M
33.86%-7.06M
Debt to assets ratio
----
-100.00%0.00%
-100.00%0.00%
-100.00%0.00%
-45.45%13.03%
-25.08%15.32%
-42.61%25.13%
-25.74%25.26%
-14.41%23.88%
-9.15%20.44%
--43.79%
--34.02%
--27.90%
--22.50%
--24.28%
----
----
----
----
----
Operating profit
49.35%-5.54M
70.71%-4.08M
65.91%-3.60M
16.86%-7.97M
-37.15%-10.94M
-85.23%-13.92M
-60.06%-10.55M
-28.27%-9.58M
-5.18%-7.97M
15.89%-7.51M
24.84%-6.59M
14.86%-7.47M
7.11%-7.58M
-21.75%-8.93M
-13.38%-8.77M
-29.31%-8.77M
4.68%-8.16M
-2.24%-7.34M
-27.74%-7.74M
36.01%-6.79M
Net Profit
-155.03%-27.70M
70.89%-4.02M
66.74%-3.51M
17.76%-7.87M
-37.40%-10.86M
-84.47%-13.81M
-55.56%-10.56M
-26.24%-9.57M
-3.51%-7.90M
17.74%-7.49M
24.15%-6.79M
17.31%-7.58M
10.07%-7.64M
-17.02%-9.10M
-10.32%-8.95M
-29.90%-9.17M
-1.22%-8.49M
-5.66%-7.78M
-27.24%-8.11M
33.86%-7.06M
Current assets
-89.10%2.45M
-73.73%8.27M
-65.59%8.10M
-52.13%15.10M
-33.03%22.43M
-22.02%31.47M
91.62%23.55M
70.21%31.55M
35.76%33.50M
22.50%40.36M
-79.60%12.29M
-72.87%18.54M
-60.66%24.67M
-52.22%32.95M
-3.68%60.26M
-3.10%68.31M
113.34%62.71M
68.61%68.96M
35.73%62.56M
30.37%70.49M
Total current liabilities
-74.87%3.31M
-76.69%3.31M
-74.77%3.52M
-50.95%7.14M
23.25%13.18M
51.10%14.22M
88.26%13.97M
68.55%14.56M
42.34%10.69M
29.33%9.41M
-69.15%7.42M
-61.48%8.64M
-63.92%7.51M
-63.66%7.28M
287.86%24.06M
128.95%22.42M
352.80%20.82M
150.73%20.03M
-12.89%6.20M
-2.90%9.79M
Total assets
-66.58%10.75M
-59.19%16.93M
-49.38%17.13M
-41.94%24.48M
-27.52%32.16M
-19.60%41.49M
41.06%33.84M
37.17%42.17M
18.88%44.38M
11.96%51.60M
-62.03%23.99M
-56.91%30.74M
-44.25%37.33M
-37.07%46.09M
-5.91%63.17M
-5.49%71.35M
111.16%66.95M
68.72%73.24M
37.48%67.14M
32.14%75.50M
Total liabilities
-52.80%9.93M
-54.11%10.26M
-51.82%10.78M
-41.73%14.70M
-11.43%21.03M
-9.96%22.36M
-11.11%22.38M
-1.94%25.23M
-9.93%23.75M
-11.23%24.84M
-30.83%25.18M
-29.35%25.73M
-29.88%26.36M
-24.63%27.98M
54.19%36.40M
33.00%36.42M
518.46%37.60M
283.36%37.12M
161.59%23.61M
124.67%27.38M
Total equity
-92.62%822.00K
-65.14%6.67M
-44.61%6.35M
-42.25%9.78M
-46.04%11.13M
-28.55%19.13M
1062.77%11.46M
237.97%16.94M
88.16%20.63M
47.80%26.77M
-104.44%-1.19M
-85.65%5.01M
-62.65%10.96M
-49.85%18.11M
-38.50%26.77M
-27.40%34.93M
14.55%29.36M
7.09%36.12M
9.35%43.54M
7.05%48.11M
Net operating income
5.45%-7.60M
64.78%-3.57M
33.42%-6.78M
-53.01%-8.43M
-11.83%-8.04M
-64.36%-10.15M
-56.96%-10.18M
13.80%-5.51M
13.45%-7.19M
4.69%-6.17M
28.49%-6.49M
24.03%-6.39M
-16.83%-8.30M
18.86%-6.48M
23.05%-9.07M
-248.87%-8.41M
-12.63%-7.11M
-50.58%-7.99M
-66.00%-11.79M
171.83%5.65M
Net investment
--0.00
100.00%0.00
100.00%0.00
100.00%0.00
100.00%0.00
57.14%-3.00K
---15.00K
-112.82%-249.00K
-265.22%-168.00K
98.03%-7.00K
100.00%0.00
-23.16%-117.00K
-1433.33%-46.00K
-1218.52%-356.00K
-871.43%-108.00K
-3.26%-95.00K
78.57%-3.00K
---27.00K
--14.00K
---92.00K
Net financing
335.23%1.70M
-79.02%3.77M
-99.16%13.00K
-73.67%1.20M
-260.22%-721.00K
-47.74%17.95M
7238.10%1.54M
283.59%4.56M
922.73%450.00K
826.81%34.35M
-94.00%21.00K
-91.74%1.19M
-96.86%44.00K
-52411.11%-4.73M
-88.95%350.00K
-74.27%14.38M
-90.61%1.40M
85.94%-9.00K
5126.98%3.17M
73630.26%55.88M

FAQs

What are the current assets of Tempest Therapeutics Inc?

According to Tempest Therapeutics Inc's FY2025 earnings report, its current assets were 8.27M, with a year-on-year change of -73.73.

What are the total assets of Tempest Therapeutics Inc?

According to Tempest Therapeutics Inc's FY2025 earnings report, its total assets of Tempest Therapeutics Inc were 16.93M, with a year-on-year change of -59.19.

What are the total liabilities of Tempest Therapeutics Inc?

According to Tempest Therapeutics Inc's FY2025 earnings report, its total liabilities of Tempest Therapeutics Inc were 10.26M, with a year-on-year change of -54.11.

What is the total equity of Tempest Therapeutics Inc?

According to Tempest Therapeutics Inc's FY2025 earnings report, its total equity of Tempest Therapeutics Inc was 6.67M, with a year-on-year change of -65.14.

What is the net operating income of Tempest Therapeutics Inc?

According to Tempest Therapeutics Inc's FY2025 earnings report, its net operating income of Tempest Therapeutics Inc was -26.57M, with a year-on-year change of 36.77.

What is the net financing of Tempest Therapeutics Inc?

According to Tempest Therapeutics Inc's FY2025 earnings report, its net financing of Tempest Therapeutics Inc was 4.26M, with a year-on-year change of -82.62.

What is the Earnings Per Share (EPS) of Tempest Therapeutics Inc?

According to Tempest Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -6.33, with a year-on-year change of 67.54.

What is the net income of Tempest Therapeutics Inc?

According to Tempest Therapeutics Inc's FY2025 earnings report, its net income was -26.26M, with a year-on-year change of 37.24.

What is the Return on Equity (ROE) of Tempest Therapeutics Inc?

According to Tempest Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -203.63, with a year-on-year change of -11.67.

What is the Return on Assets (ROA) of Tempest Therapeutics Inc?

According to Tempest Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -89.91, with a year-on-year change of -0.01.

What is the operating profit of Tempest Therapeutics Inc?

According to Tempest Therapeutics Inc's FY2025 earnings report, its operating profit was -26.57M, with a year-on-year change of 36.77.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.